Zelira Therapeutics Balances Cash Flow

Zelira Therapeutics Ltd. (AU:ZLD) has released an update.

Zelira Therapeutics Limited reported a net decrease in cash from operating activities, totaling $1,183,000 for the current quarter and an accumulated deficit of $2,916,000 over the past nine months. Despite these operating losses, the company secured a net cash inflow from financing activities amounting to $1,231,000 this quarter, primarily through HOPE SPV funding. Overall, Zelira experienced a slight increase in cash and cash equivalents with a $65,000 rise for the quarter.

For further insights into AU:ZLD stock, check out TipRanks’ Stock Analysis page.